Type 2 Diabetes

William Polonsky, PhD, CDE, explains where more benefits lie in T2D patients using the monitoring devices.

Keeping hard costs under control isn't magic and it does require some time and research, but your bottom line will thank you.

Researchers are working to identify T1D patients earlier, prevent mishaps before they occur.

5 diabetes apps at-a-glance that help patients better manage the disease and communicate with you.

How much of which foods truly promote cardiometabolic health? First-of-its-kind study quantifies impact of good food and bad.

So-called “divided dinners” are a practical strategy for people with T2D.

Benefit was seen in 5 countries regardless of SGLT2 inhibitor used.

Human antibody may substantially reduce need for insulin in patients with T1D.

Kausik Ray highlights the differences between the ODYSSEY DM-INSULIN trial differ from previous trials of PCSK9 inhibitors.

Results have major worldwide implications for type 2 diabetes treatment.

New-generation insulin found to have comparable cardiovascular safety to insulin glargine and significantly reduce episodes of severe hypoglycemia.

Swedish researchers have answered a big question about the pre-diabetic period.

Two pivotal studies on sotagliflozin were presented at the ADA’s 77th Scientific Sessions.

Insulin glargine 100 Units/mL and lixisenatide 33 mcg/mL combined lowered A1C levels by 1.09% to 2.41% after 30 weeks.

Metformin may reduce the risk of heart disease in adults with T1D.

ODYSSEY DM-DYSLIPIDEMIA is 1 of 2 studies on alirocumab presented at ADA Scientific Sessions.

ODYSSEY DM-INSULIN is 1 of 2 studies on alirocumab presented at ADA Scientific Sessions.

Merck and Pfizer have announced that VERTIS MET and VERTIS SITA met primary endpoints.

Patients who switched to insulin glargine 300 Units/mL were 57% less likely to experience hypoglycemia at 6-months.

Teens with T1D improved their A1C levels by frequent 2-way texting.

Severely obese American Indian children had a 12-times higher risk of developing T2D as normal-weight youth.

Boys who are overweight as children but normalize as young adults have the same risk of type 2 diabetes as men who were never overweight.

More than 3,000 original research presentations will be offered in a robust 5-day program.

Babies are larger at birth and twice as likely to be obese at age 7

High HbA1c levels after the percutaneous cardiovascular intervention may help identify patients at long-term risk for adverse CV events.

Glioma is less common among diabetes patients.

Sugar Sponges could absorb and expel sugar in blood as needed.

MD Magazine® Peer Exchange® recently hosted an esteemed panel in which the topic of discussion was taking the personalized approach in type 2 diabetes management.

Recent research supports an aggressive bariatric BMI-based surgery selection.

Managing of type 1 diabetes mellitus (T1DM) is a full-time job.